Drug Detail:Pulmicort (Budesonide inhalation [ byoo-des-oh-nide ])
Generic Name: BUDESONIDE 0.25mg in 2mL
Dosage Form: inhalation suspension
Drug Class: Inhaled corticosteroids
Drug Detail:Pulmicort (Budesonide inhalation [ byoo-des-oh-nide ])
Generic Name: BUDESONIDE 0.25mg in 2mL
Dosage Form: inhalation suspension
Drug Class: Inhaled corticosteroids
The recommended starting dose and highest recommended dose of PULMICORT RESPULES, based on prior asthma therapy, are listed in the following table.
Previous Therapy | Recommended Starting Dose | Highest Recommended Dose |
---|---|---|
Bronchodilators alone |
0.5 mg total daily dose administered either once daily or twice daily in divided doses |
0.5 mg total daily dose |
Inhaled Corticosteroids |
0.5 mg total daily dose administered either once daily or twice daily in divided doses |
1 mg total daily dose |
Oral Corticosteroids |
1 mg total daily dose administered either as 0.5 mg twice daily or 1 mg once daily |
1 mg total daily dose |
Dosing recommendations based on previous therapy are as follows:
In symptomatic children not responding to non-steroidal therapy, a starting dose of 0.25 mg once daily may be considered. If once-daily treatment does not provide adequate control, the total daily dose should be increased and/or administered as a divided dose. In all patients, it is desirable to downward-titrate to the lowest effective dose once asthma stability is achieved.
PULMICORT RESPULES should be administered via jet nebulizer connected to an air compressor with an adequate air flow, equipped with a mouthpiece or suitable face mask. Ultrasonic nebulizers are not suitable for the adequate administration of PULMICORT RESPULES and, therefore, are NOT recommended.
The effects of mixing PULMICORT RESPULES with other nebulizable medications have not been adequately assessed. PULMICORT RESPULES should be administered separately in the nebulizer [see Patient Counseling Information (17.1)].
A Pari-LC-Jet Plus Nebulizer (with face mask or mouthpiece) connected to a Pari Master compressor was used to deliver PULMICORT RESPULES to each patient in 3 U.S. controlled clinical studies. The safety and efficacy of PULMICORT RESPULES delivered by other nebulizers and compressors have not been established.